Biased by design? Clinical trials and patient benefit in oncology

clinical trial design, drug development, drug registration, patient benefit, risks of bias

The study by Naci et al. raises numerous questions relating to the design characteristics, risks of bias and reporting of pivotal clinical trials in oncology. These findings add to the existing body of evidence that suggests drug development in oncology is not delivering the clinical benef…

Nov 27^th • 3 mins read